ÉúÎïͨ±¨µÀ À´×ÔµÚÈý¾üÒ½´óѧµÄÑо¿ÈËԱ֤ʵ£¬ÍÌÊÉϸ°ûºôÎü±¬·¢¼¤»îÁ˾ÞÊÉϸ°û´Ùºìϸ°ûÉú³ÉËØ£¨erythropoietin£©Ðźţ¬´Ù½øÁ˼±ÐÔÑ×Ö¢ÏûÍË¡£ÕâÒ»Ñо¿·¢ÏÖ·¢²¼ÔÚ7ÔÂ11Èյġ¶×ÔȻͨѶ¡·£¨Nature Communications£©ÔÓÖ¾ÉÏ¡£

µÚÈý¾üÒ½´óѧµÄÎâÓñÕ£¨Yuzhang Wu£©½ÌÊÚ¼°ÕÅÖ¾ÈÊ£¨Zhiren Zhang£©½ÌÊÚÊÇÕâÆªÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£ÎâÓñÕ½ÌÊÚ³¤ÆÚ´ÓÊÂÃâÒßʶ±ð¡¢·Ö×ÓÉè¼ÆÓ뿹ԭ¹¤³Ì£¬ÂÊÏȽ«·Ö×ÓÉè¼ÆµÄÀíÂۺͼ¼ÊõÓ¦ÓÃÓÚÃâÒßѧ£¬ÒÔ¡°ÃâÒßʶ±ð¡¢·Ö×ÓÉè¼ÆÓ뿹ԭ¹¤³Ì¡±ÎªÑо¿·½Ïò£¬ÊÇÎÒ¹úÃâÒßѧÁìÓòµÄÖªÃûÇàÄêר¼Ò¡¢ÃâÒßʶ±ðÑо¿ÁìÓòµÄ¿ªÍØÕßÖ®Ò»£¨µÚÈý¾üÒ½´óѧNatureImmunology·¢±íÃâÒßÑ§ÖØÒª³É¹û£¬****ÎâÓñÕÂHepatology·¢±í¸ÎÑ×гɹû£©¡£

½ñÄê2Ô£¬ÎâÓñÕºÍÕÅÖ¾ÈʽÌÊÚºÏ×÷֤ʵ£¬¾ÞÊÉϸ°ûÖеĴٺìϸ°ûÉú³ÉËØÐźŴٽøÁ˱ôËÀϸ°ûÇå³ý¼°ÃâÒßÄÍÊÜ¡£ÕâÒ»Ñо¿·¢ÏÖ·¢±íÔÚImmunityÔÓÖ¾ÉÏ¡£¸ÃÑо¿¼ø±ð³öÁËÒ»¸öµ÷¿Ø¾ÞÊÉϸ°ûÇå³ý±ôËÀϸ°ûµÄÐźÅͨ·£¬½Òʾ³öÁËÕÒÎÒÐźÅS1pµÄÔ¤¼¤¹¦ÄÜ£¬·¢ÏÖÁ˺ìϸ°ûÉú³Éµ÷¿ØÒò×ÓEpOÔÚµòÍöϸ°ûÇå³ýÖÐÆð×÷Óã¬Õâ¶ÔÓÚ´¦Àí±ôËÀϸ°ûÇå³ý¾ßÓÐÖØÒªÒâÒ壨µÚÈý¾üÒ½´óѧCell×Ó¿¯·¢±íÃâÒßгɹû £©¡£

¼±ÐÔÑ×Ö¢ÊǶÔ×éÖ¯ËðÉË»ò¸ÐȾ×ö³öµÄÒ»ÖÖÉúÀí·´Ó¦£¬Æä¾ßÓÐ×ÔÏÞÐÔ£¬Í¨³£¶ÔËÞÖ÷ÓÐÒæ£»È»¶ø£¬²»ÊÜ¿ØÖƵÄÑ×Ö¢¸ß¶ÈÓк¦£¬ÊÇÐí¶à¹ã·º·¢ÉúµÄ¼²²¡È綯ÂöÖàÑùÓ²»¯¡¢·ÊÅÖÖ¢ºÍ°©Ö¢µÄ»ù´¡¡£Ô½À´Ô½¶àµÄÖ¤¾Ý±íÃ÷£¬Ñ×Ö¢ÏûÍËÊÇÔÚÑ×Ö¢·¢Æðºó¼¤·¢µÄÒ»ÖÖÖ÷¶¯³ÌÐò»¯·´Ó¦£¬ÒÔ¿ØÖÆÑ×Ö¢µÄÇ¿¶ÈºÍ³ÖÐøÊ±¼ä£¬´Ù³É×éÖ¯ÎÈ̬¡£

Ë÷È¡Èü°ÙÊ¢ DNAºÏ³É·þÎñµÄÏêϸ¼¼Êõ×ÊÁÏÇëÌîдÁªÏµ·½Ê½

¾ÞÊÉϸ°û¶ÔÕâÒ»¹ý³ÌÖÁ¹ØÖØÒª£¬ËüÃÇÇå³ýÁ˵òÍöϸ°ûºÍ×éÖ¯Ë鯬£¬Éú³ÉÁË¿¹Ñ×·Ö×ÓºÍÐÞ¸´·Ö×Óµ÷½ÚÑ×Ö¢ÏûÍË¡£×î½ü£¬·¢ÏÖÁËеÄÖ¬ÖÊÑÜÉú½éÖʼÒ×å¡°ÌØÒìÐÔ´ÙÑ×Ö¢ÏûÍ˽éÖÊ¡±£¨specialized proresolving mediator£©£¬ÓëmicroRNAsºÍÆäËûµÄһЩ·Ö×Ó£¬Í¨¹ý¶Ô¿¹µ÷¿Ø´ÙÑ×ÐźźʹٽøÑ×Ö¢ÏûÍËÐźţ¬ÔÚÑ×Ö¢Ö÷¶¯ÏûÍËÖз¢»ÓÖØÒª×÷Óá£È»¶ø¼øÓÚÑ×Ö¢µÄ¸´ÔÓÐÔ£¬µ±Ç°¼±ÐèÉîÈëÁ˽âµ÷¿ØÑ×Ö¢ÏûÍ˵ÄÄÚÔ´ÐÔÐźÅͨ·ÒÔÖ¸µ¼ÐÂÁÆ·¨¡£

ÔÚÕâÆªÎÄÕÂÖУ¬Ñо¿ÈËԱ֤ʵÍÌÊÉϸ°ûºôÎü±¬·¢ÓÕµ¼µÄȱÑõ¼¤»îÁ˾ÞÊÉϸ°û´Ùºìϸ°ûÉú³ÉËØÐźţ¬´Ù½øÁ˼±ÐÔÑ×Ö¢ÏûÍË¡£ÕâÒ»ÐźÅÊÇÔÚ¼±ÐÔ¶ø·ÇÂýÐÔÑ×Ö¢ºó±»¼¤»î¡£Ò©Îï»òÒÅ´«ÒÖÖÆºôÎü±¬·¢¿ÉÒÖÖÆÈ±ÑõºÍ¾ÞÊÉϸ°û´Ùºìϸ°ûÉú³ÉËØÐźÅ¡£¾ÞÊÉϸ°ûÌØÒìÐÔ´Ùºìϸ°ûÉú³ÉËØÊÜÌåȱÏÝСÊóºÍÂýÐÔÈâÑ¿Öײ¡£¨CGD£©Ð¡Êóȱ·¦ºôÎü±¬·¢ÄÜÁ¦£¬ÏÔʾ³öÑ×Ö¢ÏûÍËÊÜËð£¬ÍâÔ´ÐԵĴٺìϸ°ûÉú³ÉËØ¿É´Ù½øÒ°ÉúÐͺÍCGDСÊóÖеÄÕâÖÖÑ×Ö¢ÏûÍË¡£»úÖÆÑо¿±íÃ÷£¬´Ùºìϸ°ûÉú³ÉËØÍ¨¹ýppAR¦ÃÔö¼ÓÁ˾ÞÊÉϸ°ûÍÌʳµòÍöÖÐÐÔÁ£Ï¸°û£¬´Ù½øÁ˾ÞÊÉϸ°û³ýÈ¥Ë鯬£¬Íƶ¯Á˾ÞÊÉϸ°ûÇ¨ÒÆµ½ÒýÁ÷ÁܰͽáÖС£

ÕâЩÑо¿½á¹ûÌṩÁËÖØÒªµÄÖ¤¾Ý֤ʵ£¬Ò»ÌõÄÚÔ´ÐÔÐźÅͨ·µ÷¿ØÁËÑ×Ö¢ÏûÍË£¬Õâ¶ÔÓÚÖÎÁÆÒ»Ð©Ñ×Ö¢ÐÔ¼²²¡¾ßÓÐÖØÒªµÄÒâÒå¡£

£¨ÉúÎïͨ£ººÎæÍ£©

ÉúÎïÍ¨ÍÆ¼öÔ­ÎÄÕªÒª£º

phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution

Inflammation resolution is an active process, the failure of which causes uncontrolled inflammation which underlies many chronic diseases. Therefore, endogenous pathways that regulate inflammation resolution are fundamental and of wide interest. Here, we demonstrate that phagocyte respiratory burst-induced hypoxia activates macrophage erythropoietin signalling to promote acute inflammation resolution. This signalling is activated following acute but not chronic inflammation. pharmacological or genetical inhibition of the respiratory burst suppresses hypoxia and macrophage erythropoietin signalling. Macrophage-specific erythropoietin receptor-deficient mice and chronic granulomatous disease (CGD) mice, which lack the capacity for respiratory burst, display impaired inflammation resolution, and exogenous erythropoietin enhances this resolution in WT and CGD mice. Mechanistically, erythropoietin increases macrophage engulfment of apoptotic neutrophils via ppAR¦Ã, promotes macrophage removal of debris and enhances macrophage migration to draining lymph nodes. Together, our results provide evidences of an endogenous pathway that regulates inflammation resolution, with important implications for treating inflammatory conditions.

×÷Õß¼ò½é£º

ÎâÓñÕÂ

½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£ÏÖÈεÚÈý¾üÒ½´óѧÃâÒßѧ½ÌÑÐÊÒÖ÷ÈΣ¬È«¾ü·Ö×ÓÃâÒßÑ§ÖØµã£¨¿ª·Å£©ÊµÑéÊÒÖ÷ÈΣ¬È«¾üÃâÒßѧÑо¿ËùËù³¤£¬ÖØÇìÊжàëÄÒ©Î﹤³Ì¼¼ÊõÑо¿ÖÐÐÄÖ÷ÈΣ¬ÖØÇìÊÐÉúÎïÐÅϢѧÑо¿ËùËù³¤¡£¼æÈÎÖйúÃâÒßѧ»á³£ÎñÀíÊ£¬Öйú»ù´¡ÃâÒßѧ»áÖ÷ÈÎίԱ£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðѧ¿ÆÆÀÒé×é³ÉÔ±£¬¹ú¼ÒÐÂÒ©ÉóÆÀίԱ»áר¼Ò£¬È«¾üÃâÒßѧרҵίԱ»á¸±Ö÷ÈÎίԱ£»Êǹú¼Ò½ÌÓý²¿****ÌØÆ¸½ÌÊÚ£¬¹ú¼Ò½Ü³öÇàÄê»ù½ð»ñµÃÕߣ¬¹úÎñÔºÕþ¸®ÌØÊâ½òÌù»ñµÃÕߣ¬È«¹úҽѧÖÐÇàÄê°ÙÃû¿Æ¼¼Ö®ÐÇ£¬×ܺóÇÚ²¿ÔºÊ¿ºó±¸ÈËÑ¡£¬×ܺóÇÚ²¿¿Æ¼¼ÒøÐÇ£¬ÖØÇìÊÐ×ÔÈ»¿ÆÑ§Ò»µÈ½±»ñµÃÕß¡£

ÎâÓñÕ½ÌÊÚÊÇÎÒ¹ú¡¢ÎÒ¾üÃâÒßѧÁìÓòµÄÖªÃûÇàÄêר¼Ò£¬ÃâÒßʶ±ðÑо¿ÁìÓòµÄ¿ªÍØÕßÖ®Ò»¡£³¤ÆÚ´ÓÊÂÃâÒßʶ±ð¡¢·Ö×ÓÉè¼ÆÓ뿹ԭ¹¤³Ì£¬ÂÊÏȽ«·Ö×ÓÉè¼ÆµÄÀíÂۺͼ¼ÊõÓ¦ÓÃÓÚÃâÒßѧ£¬ÒÔ¡°ÃâÒßʶ±ð¡¢·Ö×ÓÉè¼ÆÓ뿹ԭ¹¤³Ì¡±ÎªÑо¿·½Ïò£¬¿ªÍØÁËÃâÒßѧÑо¿µÄÐÂÁìÓò¡£